As of 2025-01-25, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (903.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 354.79 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -354.8%.
The range of the Relative Valuation is (876.03) - (908.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.5x - 35.5x | 34.4x |
| Forward P/E multiples | 27.7x - 32.7x | 30.6x |
| Fair Price | (876.03) - (908.29) | (903.84) |
| Upside | -346.9% - -356.0% | -354.8% |
| Date | P/E |
| 2025-01-24 | -12.76 |
| 2025-01-23 | -12.67 |
| 2025-01-22 | -12.96 |
| 2025-01-21 | -12.72 |
| 2025-01-17 | -12.31 |
| 2025-01-16 | -12.39 |
| 2025-01-15 | -12.29 |
| 2025-01-14 | -12.31 |
| 2025-01-13 | -12.65 |
| 2025-01-10 | -12.29 |
| 2025-01-08 | -12.38 |
| 2025-01-07 | -12.37 |
| 2025-01-06 | -12.35 |
| 2025-01-03 | -11.89 |
| 2025-01-02 | -11.73 |
| 2024-12-31 | -11.81 |
| 2024-12-30 | -11.73 |
| 2024-12-27 | -11.90 |
| 2024-12-26 | -11.92 |
| 2024-12-24 | -11.89 |
| 2024-12-23 | -11.81 |
| 2024-12-20 | -11.78 |
| 2024-12-19 | -11.72 |
| 2024-12-18 | -11.65 |
| 2024-12-17 | -12.15 |
| 2024-12-16 | -12.33 |
| 2024-12-13 | -12.09 |
| 2024-12-12 | -12.23 |
| 2024-12-11 | -12.28 |
| 2024-12-10 | -12.22 |
| 2024-12-09 | -12.43 |
| 2024-12-06 | -11.70 |
| 2024-12-05 | -11.59 |
| 2024-12-04 | -12.17 |
| 2024-12-03 | -11.95 |
| 2024-12-02 | -12.18 |
| 2024-11-29 | -12.24 |
| 2024-11-27 | -12.17 |
| 2024-11-26 | -12.14 |
| 2024-11-25 | -12.09 |
| 2024-11-22 | -11.97 |
| 2024-11-21 | -11.71 |
| 2024-11-20 | -11.64 |
| 2024-11-19 | -11.53 |
| 2024-11-18 | -11.26 |
| 2024-11-15 | -11.52 |
| 2024-11-14 | -12.59 |
| 2024-11-13 | -13.06 |
| 2024-11-12 | -13.11 |
| 2024-11-11 | -13.16 |